| | SEPTEMBER 20226CIOReviewThe onset of COVID-19 has brought unprecedented transformation in the drug development landscape with greater involvement of technology. Tech solutions have become indispensable to ensure novel and effective drugs reach clinical trials, get approved, and eventually hit the markets rapidly and transparently. In tandem, the global market for pharma and life sciences tech solutions is estimated to grow from $11 billion in 2020 to reach $18 billion by 2025, increasing at a CAGR of 11 percent.The chief drivers for this market expansion are expanding R&D activities worldwide, strict regulatory compliance and reporting, increasing use of artificial intelligence and machine learning in drug discovery and clinical trial phases, and rising demand for innovative software solutions for biologics, cell, and gene therapy. The growth is also propelled by pharma and biotech firms' mounting use of deep learning software tools to speed up drug development, cut costs during research and preclinical stages, and improve overall transparency.This edition of CIOReview showcases the key developments in the pharma and life sciences tech solutions space and how pharma and biotech companies are using them to streamline and fast-track drug discovery and development. It features thought leadership articles from Nick Thomson, Senior Director, Chemical Research and Development at Pfizer, Inc. and Carlos Pedraza, PhD, Director of CNS Biology at Alkermes. They speak about the importance of aligning capital investments, collaborative cultures, and complex operations in drug discovery to revolutionize small molecule bio-product development and the need to balance innovation in early-stage drug discovery with validation in later-stage clinical trials.The edition also features Tenthpin, a leading business and technology consultancy that empowers life sciences companies to better manage their drug development process. As an industry innovation partner for SAP, the company augments clinical supply management through front-end engineering strategies that deploy SAP co-innovations, RPA, and data analytics.In this edition featuring the most promising pharma and life sciences tech solution providers, we hope you find the appropriate company to enhance and optimize your drug discovery and manufacturing requirements. Let us know your thoughts!EditorialShifting Paradigms in Drug DiscoveryCopyright © 2022 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.CIOReviewEmail:sales@cioreview.comeditor@cioreview.commarketing@cioreview.com September - 29 - 2022, Vol 11, Issue - 57 (ISSN 2644-237X) Published by ValleyMedia, Inc.To subscribe to CIOReviewVisit www.cioreview.com CIOReviewEditorial StaffAaron PierceCarolynn WaltersShirley FaithRussell ThomasGina ClumskyYenny TurnerTiffany HayworthAbner LawrenceVisualizersChris LynnBrian Harding*Some of the Insights are based on our interviews with CIOs and CXOsJustin Smith Managing Editoreditor@cioreview.comManaging EditorJustin Smith
< Page 5 | Page 7 >